Abstract
This case report highlights an ocular complication associated with platelet-rich plasma
temporomandibular joint injections. This pioneering treatment can risk irreversible
visual loss. This case highlights the importance of an experienced technique, in depth
understanding of facial anatomy, and promptly recognising and referring the patient
to a specialist to manage the complication should it arise.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to British Journal of Oral and Maxillofacial SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Current Understanding of Pathogenesis and Treatment of TMJ Osteoarthritis.Beijing : Journal of Dental Research. 2015;
- Clinical and Radiological Comparison of Effects of Platelet-Rich Plasma, Hyaluronic Acid, and Corticosteroid Injections on Temporomandibular Joint Osteoarthritis.The Journal of Craniofacial Surgery. 2019; 30
- Temporomandibular disorders (TMD).NICE, London2016
- Platelet Rich Plasma and Hyaluronic Acid Blend for the Treatment of Osteoarthritis: Rheological and Biological Evaluation.PLOS ONE. 2016;
- The Efficacy of Platelets Rich Plasma Injection in the Superior Joint Space of the Tempromandibular Joint Guided by Ultra Sound in Patients with Non-reducing Disk Displacement.Journal of Maxillo-facial Oral Surgery. 2016; 16
- The arterial blood supply of the temporomandibular joint: an anatomical study and clinical implications.Imaging Science in Dentistry. 2012; 43
- Central Retinal Artery Occlusion: Visual Outcome.American Journal of Ophthalmology. 2005; 140
Article info
Publication history
Published online: September 12, 2020
Accepted:
August 11,
2020
Identification
Copyright
Crown Copyright © 2020 Published by Elsevier Ltd on behalf of The British Association of Oral and Maxillofacial Surgeons. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Corrigendum to “Blindness associated with platelet-rich plasma temporomandibular joint injections” [Br. J. Oral Maxillofac. Surg. 58(9) (2020) 1197–1199]British Journal of Oral and Maxillofacial SurgeryVol. 60Issue 7
- PreviewThe authors regret to inform that the blindness by embolisation was caused by activated mesenchymal pericyte plasma injections, which is also known as LIpgems© rather than ‘Platelet-rish plasma’ injection. In the original publication, the authors found only one previous ‘Platelet-rich plasma’ injection associated blindness however, in the case of LIpgems© there was no evidence whatsoever in the literature. Despite the change in the type of the treatment the patient received, the case report maintains its rarity and learning point of disclosing visual loss as a rare complication of any temporomandibular injection.
- Full-Text
- Preview
